% Appendix A

\chapter{List of BioASQ questions used for the manual evaluation} % Main appendix title

\label{AppendixA} % For referencing this appendix elsewhere, use \ref{AppendixA}

%\appendix
%\section{List of BioASQ questions used for the manual evaluation}
\begin{enumerate}
  \item Which is the gene most commonly mutated in Tay-Sachs disease? \newline (identifier 536e46f27d100faa09000012)
  \item What medication were compared in the ROCKET AF Trial? \newline (identifier 56bb616dac7ad10019000008)
  \item Which enzyme does MLN4924 inhibit? (id 56ed03862ac5ed1459000004)
  \item Where is the protein Pannexin1 located? \newline (identifier 56af9f130a360a5e45000015)
  \item RTS S AS01 vaccine was developed to prevent which disease? \newline (identifier 56bc77a3ac7ad10019000015)
  \item Which type of myeloma is ixazomib being evaluated for? \newline (identifier 56ed0ffe2ac5ed1459000008)
  \item What enzyme is inhibied by Opicapone? (id 56c1d857ef6e394741000033)
  \item Which gene has been implicated in Majeed Syndrome? (id 56f7c15a09dd18d46b000012)
  \item Which gene is most commonly associated with severe congenital and cyclic neutropenia? \newline (identifier 5503133ae9bde6963400001d)
  \item Which is the receptor for the immunosuppressive drug cyclosporin A (CsA)? \newline (identifier 56f6c11109dd18d46b00000e)
  \item Which proteins participate in the formation of the Notch transcriptional activation complex? \newline (identifier 54fb6fb5d176fff445000004)
  \item What is being measured with an accelerometer in back pain patients? \newline (identifier 533f9df0c45e133714000016)
  \item List inhibtors targeting the mitochondrial permeability transition pore. \newline (identifier 5717cdd2070aa3d072000001)
  \item List symptoms of the IFAP syndrome. \newline (identifier 56c1f038ef6e394741000051)
  \item What is the functional role of the protein Drp1? \newline (identifier 5717dbfe7de986d80d000001)
  \item Which receptors are bound by Tasimelteon? \newline (identifier 56c1f043ef6e394741000057)
  \item Which disease phenotypes are associated to PRPS1 mutations? \newline (identifier 5713b0a51174fb175500000e)
  \item Which genes are thought to be involved in medulloblastoma development? \newline (identifier 5539029cbc4f83e828000012)
  \item Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer? \newline (identifier 553fa78b1d53b76422000007)
  \item Which interleukins are inhibited by Dupilumab? \newline (identifier 56c1f005ef6e39474100003a)
  \item Which are the genes thought to be regulated by EWS/FLI? \newline (identifier 552faa43bc4f83e828000004)
  \item Is the ACE inhibitor indicated for lung cancer treatment? \newline (identifier 530cf4fe960c95ad0c000005)
  \item Is PTEN involved in follicular thyroid carcinoma? \newline (identifier 55031650e9bde69634000026)
  \item Is Fanconi anemia presented as a genetically and clinically heterogeneous disease entity? \newline (identifier 54ede5c394afd61504000006)
  \item Can the iPS cell technology be used in Fanconi anemia therapy? \newline (identifier 54edef0594afd6150400000d)
  \item Does surgery for ovarian endometriomas improve fertility? \newline (identifier 54f088ee94afd61504000015)
  \item Is irritable bowel syndrome more common in women with endometriosis? \newline (identifier 54f08d4a94afd61504000016)
  \item Is the regulation of Vsr endonuclease independent of the growth phase of bacteria? \newline (identifier 553fbe9fe00431e071000001
  \item Does TRIM37 gene mutation causes Mulibrey nanism? \newline (identifier 56c1f03cef6e394741000054)
  \item Is the gene MAOA epigenetically modified by methylation? \newline (identifier 56cf50253975bb303a00000b)






\end{enumerate}
